Nuvation Bio Inc (NUVB)
3.245
-0.08
(-2.55%)
USD |
NYSE |
May 10, 16:00
3.245
0.00 (0.00%)
After-Hours: 20:00
Nuvation Bio Total Liabilities (Quarterly): 16.36M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.36M |
| September 30, 2023 | 19.28M |
| June 30, 2023 | 16.78M |
| March 31, 2023 | 15.99M |
| December 31, 2022 | 17.06M |
| September 30, 2022 | 18.55M |
| June 30, 2022 | 26.66M |
| Date | Value |
|---|---|
| March 31, 2022 | 28.24M |
| December 31, 2021 | 30.15M |
| September 30, 2021 | 28.42M |
| June 30, 2021 | 25.33M |
| March 31, 2021 | 25.72M |
| December 31, 2020 | 6.708M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.708M
Minimum
Dec 2020
30.15M
Maximum
Dec 2021
21.17M
Average
19.28M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| iBio Inc | 24.82M |
| Flora Growth Corp | 17.22M |
| Lixte Biotechnology Holdings Inc | 0.3139M |
| Replimune Group Inc | 111.39M |
| ABVC BioPharma Inc | 6.362M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 621.48M |
| Shareholders Equity (Quarterly) | 605.12M |